NeuroOne Medical Technologies Corporation announced the appointment of Kip Ludwig as to chair and for the creation of a new Artificial Intelligence Advisory Board. The advisory board, comprised of six additional members with experience in industry, clinical practice, medical research and the FDA, will focus on the potential use of NeuroOne’s electrode technology in artificial intelligence and bioelectronics applications. Dr. Ludwig, along with the advisory board members, will provide guidance to the company on potential applications in translational neuroscience settings, including artificial intelligence and neuromodulation for medical applications.